Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How Long Does It Take for Clopidogrel and Ticagrelor to Inhibit Platelets in Patients Undergoing Primary Percutaneous Coronary Intervention? A Detailed Pharmacodynamic Analysis: Time Course of Platelet Reactivity in STEMI (TOPS).
Bergmeijer TO, Godschalk TC, Janssen PWA, Berge KVD, Breet NJ, Kelder JC, Hackeng CM, Ten Berg JM. Bergmeijer TO, et al. Among authors: godschalk tc. Semin Thromb Hemost. 2017 Jun;43(4):439-446. doi: 10.1055/s-0037-1599156. Epub 2017 Apr 4. Semin Thromb Hemost. 2017. PMID: 28561235 Clinical Trial.
The hypercoagulable profile of patients with stent thrombosis.
Loeffen R, Godschalk TC, van Oerle R, Spronk HM, Hackeng CM, ten Berg JM, ten Cate H. Loeffen R, et al. Among authors: godschalk tc. Heart. 2015 Jul;101(14):1126-32. doi: 10.1136/heartjnl-2014-306685. Epub 2015 May 21. Heart. 2015. PMID: 25999588 Free PMC article.
Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.
Godschalk TC, Byrne RA, Adriaenssens T, Malik N, Feldman LJ, Guagliumi G, Alfonso F, Neumann FJ, Trenk D, Joner M, Schulz C, Steg PG, Goodall AH, Wojdyla R, Dudek D, Wykrzykowska JJ, Hlinomaz O, Zaman AG, Curzen N, Dens J, Sinnaeve P, Desmet W, Gershlick AH, Kastrati A, Massberg S, Ten Berg JM; PRESTIGE Investigators. Godschalk TC, et al. JACC Cardiovasc Interv. 2017 Dec 26;10(24):2548-2556. doi: 10.1016/j.jcin.2017.09.019. JACC Cardiovasc Interv. 2017. PMID: 29268884 Free article.
A clinical risk score to identify patients at high risk of very late stent thrombosis.
Godschalk TC, Gimbel ME, Nolet WW, van Kessel DJ, Amoroso G, Dewilde WJ, Wykrzykowska JJ, Janssen PW, Bergmeijer TO, Kelder JC, Heestermans T, Ten Berg JM. Godschalk TC, et al. J Interv Cardiol. 2018 Apr;31(2):159-169. doi: 10.1111/joic.12494. Epub 2018 Feb 22. J Interv Cardiol. 2018. PMID: 29468725 Free article.
Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
Joner M, Koppara T, Byrne RA, Castellanos MI, Lewerich J, Novotny J, Guagliumi G, Xhepa E, Adriaenssens T, Godschalk TC, Malik N, Alfonso F, Tada T, Neumann FJ, Desmet W, Ten Berg JM, Gershlick AH, Feldman LJ, Massberg S, Kastrati A; Prevention of PRESTIGE Investigators. Joner M, et al. Among authors: godschalk tc. JACC Cardiovasc Interv. 2018 Jul 23;11(14):1340-1350. doi: 10.1016/j.jcin.2018.02.029. JACC Cardiovasc Interv. 2018. PMID: 30025727 Free article.
18 results